PI3K, a key kinase in skeletal muscle, mediates glucose entry into myofibers by regulating upstream factors of the insulin signaling pathway, thereby modulating GLUT4 translocation and improving insulin release, which alleviates T2DM (Widerska et al., 2018). The gene discussed is INS; the disease is type 2 diabetes mellitus.